Mayor Isko has enough antibodies vs severe COVID-19 after 2nd dose of CoronaVac حسب Aro, Andrea

State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2 biopharmaceutical characterization: the NISTmAb case study

Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy

State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 3 defining the next generation of analytical and biophysical techniques

Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy

State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization

Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy

Bispecific antibodies

Available for University of the Philippines Diliman via SpringerLink. Click here to access

Antibody expression and production

Available for University of the Philippines Diliman via SpringerLink. Click here to access

Handbook of therapeutic antibodies technologies, emerging developments and approved therapeutics

Generation of single-chain variable antibody fragments (scFv) against dengue virus by phage display حسب Dapat, Clyde Pancito

Antibody therapeutics

Antibody engineering a practical approach